Dr. Priyadarshini Kachroo received her Ph.D. in Natural Sciences at the University of Kiel, Germany (2016). As a postdoctoral fellow and Instructor at the Brigham and Women’s Hospital and Harvard Medical School in Boston, Dr. Kachroo utilized multiple large-scale, well-characterized population-based cohorts and clinical trial data with comprehensive coverage of the various ‘omes’ (whole genome, metabolome, transcriptome, methylome, quantitative trait loci – QTLs) and led various studies to establish early-life origins of respiratory diseases including asthma and chronic obstructive pulmonary disease (COPD). Dr. Kachroo has received the K99/R00 award from the National Heart, Lung and Blood Institute (NHLBI), whose primary focus is to identify integrative genetic, epigenetic and metabolomic biomarkers by using machine learning and network methods to examine inflammatory pathways predictive of an early decline in lung function in children with asthma. Her long-term goal is to study gene-environment interactions across life-course and gain insights into the most complete profile of disease development through multi-omic integration. Dr. Kachroo has published over 30 research articles in prestigious national and international journals including European Respiratory Journal, Nature Medicine, Scientific Reports, and eBioMedicine, given several talks at national and international conferences and serves as an editorial board member for PlosOne and peer reviewer for several esteemed academic journals.
Dr. Kachroo joined the Department of Biomedical and Health Informatics, Rutgers School of Health Professions at RBHS as an Assistant Professor and the Center for Immunity and Inflammation, i3D as a core Member in June 2024.